Johnson & Johnson Slides By With Q2 Earnings
Johnson & Johnson retreated though it reported better than expected second-quarter before the markets opened on Tuesday.
Johnson & Johnson retreated though it reported better than expected second-quarter before the markets opened on Tuesday.
Gilead and Galapagos each saw shares shoot up on Monday after the companies announced a new collaboration.
Johnson & Johnson is scheduled to report its most recent quarterly results before the markets open on Tuesday.
Capricor Therapeutics shares more than doubled on Monday after the firm announced interim analysis for its Duchenne muscular dystrophy midstage trial.
Alkermes shares made a handy gain on Monday after the firm announced that it would be expanding its New Drug Application for ALKS 3831 to encompass the treatment of bipolar I disorder in addition…
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The June 28 short interest data has been compared with the previous report, and short interest in most of these…
Illumina shares dropped on Friday after the firm announced a preliminary revenue miss and a 50% cut to its 2019 revenue growth guidance. As a result, a few analysts were quick to weigh in…
Hookipa Pharma is not a household name, or even well-known within the biotech industry, but it is making waves on Friday after the firm announced an update from the FDA.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The June 28 short interest data has been compared with the previous report, and short interest in most of these…
The June 28 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were increased.
Sangamo Therapeutics made a handy gain to start out the week after the firm, in conjunction with Pfizer, announced updated results from a mid-stage trial evaluating a treatment for hemophilia.
President Trump lost ground with his efforts to force drug companies to list drug prices on TV ads, with the effort being blocked on free speech concerns.
Microsoft announced that it is working with Providence St. Joseph Health, a U.S. hospital chain, in an effort to build a new high-tech hospital.
A federal District Court judge on Tuesday ruled that the U.S. Department of Health and Human Services could not force drug companies to include drug prices in their TV ads. But the saga may…
Sangamo Therapeutics made a handy gain to start out the week after the firm, in conjunction with Pfizer, announced updated results from a mid-stage trial evaluating a treatment for hemophilia.